RENAISSANCE TECHNOLOGIES LLC
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in ZNTL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,804,028
+$3,268,769 QoQ
Shares Held
1,609,078
-17.0% QoQ
Ownership
2.25%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 114 holders
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. ZNTL ranks #63 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in ZNTL
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,804,028 | 1,609,078 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,535,259 | 1,938,145 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,893,055 | 2,883,745 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,511,286 | 2,325,355 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,774,281 | 1,529,553 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,313,405 | 826,041 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,634,215 | 539,345 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,049,553 | 556,944 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,706,279 | 661,682 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,128,127 | 261,937 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,685,546 | 309,277 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,725,866 | 285,437 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,936,427 | 210,437 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $563,076 | 32,737 | Shares | Sole | 2023-05-12 | |
| 2022-03-31 | $5,044,809 | 109,337 | Shares | Sole | 2022-05-13 | |
| 2021-09-30 | $2,088,297 | 31,337 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $332,260 | 6,397 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||